S100A11, an dual mediator for growth regulation of human keratinocytes

被引:78
|
作者
Sakaguchi, Masakiyo [1 ]
Sonegawa, Hiroyuki [1 ]
Murata, Hitoshi [1 ,2 ]
Kitazoe, Midori [2 ]
Futami, Jun-ichiro [2 ]
Kataoka, Ken [1 ]
Yamada, Hidenori [2 ]
Huh, Nam-ho [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Okayama 7008530, Japan
关键词
D O I
10.1091/mbc.E07-07-0682
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We previously revealed a novel signal pathway involving S100A11 for inhibition of the growth of normal human keratinocytes (NHK) caused by high Ca++ or transforming growth factor beta. Exposure to either agent resulted in transfer of S100A11 to nuclei, where it induced p21(WAF1). In contrast, S100A11 has been shown to be overexpressed in many human cancers. To address this apparent discrepancy, we analyzed possible new functions of S100A11, and we provide herein evidence that 1) S100A11 is actively secreted by NHK; 2) extracellular S100A11 acts on NHK to enhance the production of epidermal growth factor family proteins, resulting in growth stimulation; 3) receptor for advanced glycation end products, nuclear factor-kappa B, Akt, and cAMP response element-binding protein are involved in the S100A11-triggered signal transduction; and 4) production and secretion of S100A11 are markedly enhanced in human squamous cancer cells. These findings indicate that S100A11 plays a dual role in growth regulation of epithelial cells.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [31] Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11
    Sun, Qigang
    Fu, Cexiong
    Liu, Jun
    Li, Shibing
    Zheng, Jinfang
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2023, 53 (02): : 212 - 221
  • [32] S100A11 facilitates the migratory, invasive, and proliferative capacity of NSCLC
    Mohammed, Tareg O.
    Nishikawaji, Taketo
    Ogama, Naoko
    Tanaka, Nobuyuki
    CANCER SCIENCE, 2018, 109 : 1421 - 1421
  • [33] S100A11 is a prominent therapeutic target in malignant pleural mesothelioma
    Sato, Hiroki
    Yamamoto, Hiromasa
    Namba, Kei
    Torigoe, Hidejiro
    Yoshioka, Takahiro
    Shien, Kazuhiko
    Soh, Junichi
    Toyooka, Shinichi
    CANCER RESEARCH, 2017, 77
  • [34] S100A11 protein is overexpressed in common human cancers with spatial translocation from the nucleus to cytoplasm
    Cross, SS
    Hamdy, FC
    Deloulme, JC
    Rehman, I
    JOURNAL OF PATHOLOGY, 2004, 204 : 10A - 10A
  • [35] Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
    Hiroki Sato
    Masakiyo Sakaguchi
    Hiromasa Yamamoto
    Shuta Tomida
    Keisuke Aoe
    Kazuhiko Shien
    Takahiro Yoshioka
    Kei Namba
    Hidejiro Torigoe
    Junichi Soh
    Kazunori Tsukuda
    Hiroyuki Tao
    Kazunori Okabe
    Shinichiro Miyoshi
    Harvey I. Pass
    Shinichi Toyooka
    Oncogenesis, 7
  • [36] CALGIZZARIN (S100A11) IS UP-REGULATED IN RHEUMATOID ARTHRITIS
    Cerezo, L. Andres
    Prajzlerova, K.
    Veigl, D.
    Pavelka, K.
    Vencovsky, J.
    Senolt, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 829 - 829
  • [37] The Calcium Binding Protein S100A11 and Its Roles in Diseases
    Zhang, Linqiang
    Zhu, Tingting
    Miao, Huilai
    Liang, Bin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [38] Formation of Monomeric S100B and S100A11 Proteins at Low Ionic Strength
    Marlatt, Nicole M.
    Boys, Brian L.
    Konermann, Lars
    Shaw, Gary S.
    BIOCHEMISTRY, 2009, 48 (09) : 1954 - 1963
  • [39] Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer
    Cui, Yuxin
    Li, Liting
    Li, Zhilei
    Yin, Jie
    Lane, Jane
    Ji, Jiafu
    Jiang, Wen G.
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [40] Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer
    Yuxin Cui
    Liting Li
    Zhilei Li
    Jie Yin
    Jane Lane
    Jiafu Ji
    Wen G. Jiang
    Cancer Cell International, 21